1. AstraZeneca pays Sobi $95M for priority review voucher — Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study — Retrophin sinks as drug “Pharma Bro” Martin Shkreli co-invented fails — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Current IT "leadership" will cease to exist once the new CEO is installed

Discussion in 'Johnson & Johnson IT' started by anonymous, Mar 20, 2019 at 1:31 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    The $hit has not yet begun to hit the fan. Basically all long term white male IT VPs (TW, ZD, etc) will be gone by EOY. They simply have under performed and are antique relics at this point. We need more D&I and young blood that can really transform the organization!
     
  2. anonymous

    anonymous Guest

    Thanks Nostradamus.
     
  3. anonymous

    anonymous Guest

    Humm, only white males have under performed, interesting.
     
  4. anonymous

    anonymous Guest

    Obviously, NOT ONLY WHITE MALES have underperformed, But, they will continue to be scapegoated in the era of D&I . Remember, Alex is an old white male and in order to hang on as long as possible, he will kill as many of his own kind as needed. Moreover, D&I replacements are much less expensive alternatives to the remaining good ole white boys in the IT LT. All good things come to end!
     
  5. anonymous

    anonymous Guest

    Wow, just wow. So its not the best person but the person who is not male or white.
     
  6. MAGA

    MAGA Guest

    WOW is Right, How are you living the Credo motto? You've learned nothing and I have to say you're coming off a little Insecure, with Sexiest, Ageism and Racist tendencies!
    What about hiring the best person possible regardless of any category they fall in!